We evaluated our algorithm using three known anti-AD drug targets, acetylcholinesterase, TREM2 and APOE, which revealed a medium/high target score of 0.384, 0.459 and 0.887, respectively [S7 Table]. Here, ACHE is linked to Alzheimer disease.